COURIER HEALTH RAISES $50M SERIES B FOR AI BIOPHARMA PLATFORM
AI DESK■ 1 MIN READ
THU, APR 23, 2026■ AI-SUMMARIZED FROM 2 SOURCES ▸ TIMELINE
Courier Health, an AI-powered biopharma platform, secured $50 million in Series B funding led by Oak HC/FT. The platform manages the end-to-end patient experience for pharmaceutical companies.
The funding round included participation from Norwest Venture Partners. Courier Health's platform addresses a critical gap in drug development and patient management by automating and optimizing the complete patient journey from prescription through treatment completion.
The company focuses on medication adherence and patient experience management, areas where pharmaceutical companies traditionally struggle. By leveraging AI, Courier Health streamlines workflows that typically involve multiple disconnected systems and manual processes.
This Series B round brings total funding to the company and validates the growing market demand for digital health solutions in the biopharma sector. The capital will likely support product expansion and go-to-market initiatives as healthcare companies increasingly prioritize patient experience metrics alongside clinical outcomes.
Courier Health joins a wave of startups modernizing pharmaceutical operations through automation and data analytics.
■ MORE FROM THE STARTUPS DESK
Triomics, an AI platform automating data-heavy tasks for oncologists, secured $22M in Series B funding. The raise follows a $15M Series A in 2024.
23H AGO— AI Desk
Xcena secured $135 million in Series B funding at a $570 million valuation for its MX1 chip, which handles data orchestration and KV cache management directly within memory modules.
23H AGO— AI Desk
Pittsburgh-based Gray Swan, which stress-tests AI models for frontier labs, secured $40M in Series A funding at a $200M valuation. The round was co-led by Wing VC and Madrona.
YESTERDAY— AI Desk
H1, a healthcare SaaS startup, secured $40 million in funding from CVS Health. The investment signals continued investor confidence in specialized software platforms despite AI disruption concerns.
YESTERDAY— Industry Desk